Funding will enable ViAqua to bring its first product to market, invest in R&D for future products, and prove the platform’s ability to deliver RNA-based solutions at scale. HAIFA, Israel, Sept. 5, 2023 /PRNewswire/ — ViAqua Therapeutics, a biotechnology company and developer of an…